NCR3 and acute myeloid leukemia: In previous studies, we have reported that AML patients strongly upregulate expression of NKp30 in response to HDC/IL-2 immunotherapy (16), and that high NKp30 expression is associated with improved LFS and OS in elderly AML patients (35).